Literature DB >> 23917409

Treatment of coronary artery disease via MIDCAB in a patient with severe thalidomide phocomelia.

Maximilian Scherner1, Maria Mihaijlova, Navid Madershahian, Thorsten Wahlers, Jens Wippermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23917409     DOI： 10.1007/s00392-013-0605-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  4 in total

Review 1.  Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.

Authors:  M T Miller; K Strömland
Journal:  Teratology       Date:  1999-11

2.  Thalidomide's long and winding road.

Authors:  L Hanna
Journal:  BETA       Date:  1998-04

3.  Identification of a primary target of thalidomide teratogenicity.

Authors:  Takumi Ito; Hideki Ando; Takayuki Suzuki; Toshihiko Ogura; Kentaro Hotta; Yoshimasa Imamura; Yuki Yamaguchi; Hiroshi Handa
Journal:  Science       Date:  2010-03-12       Impact factor: 47.728

Review 4.  Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects.

Authors:  Jürgen Knobloch; Ulrich Rüther
Journal:  Cell Cycle       Date:  2008-02-14       Impact factor: 4.534
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.